An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer

NCT01712347 · clinicaltrials.gov ↗

COMPLETED

Status

351

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Bevacizumab
DRUG: Chemotherapy

Sponsor

Hoffmann-La Roche